Optimal use of immunoglobulins in dermatology

12-14-2020 | Médicaments: Usage optimal

Given that there is insufficient evidence regarding the efficacy of subcutaneous immunoglobulins (Igs) for the treatment of dermatological diseases, INESSS has developed a specific optimal use guide on intravenous Igs in dermatology.

 

REF646

Subscribe to our newsletter now

Subscription